Skip to main content

Our research focuses on (i) the elucidation of molecular mechanisms of erythropoiesis (red blood cell differentiation), (ii) the pathophysiology of red cell disorders with a focus on sickle cell disease and (iii) the genetics underlying the persistence of foetal haemoglobin. We are employing a combination of cutting-edge molecular, cellular, genetic, genomic and bioinformatic tools, to elucidate the molecular pathways of erythroid differentiation in health and in disease, with the aim of developing improved diagnostics and novel effective treatments for red cell disorders. Our research laboratory consists of basic scientists and clinical fellows working closely with clinicians at King’s College Hospital and Guy’s Hospital and in collaboration with other research groups throughout the world (see list of partners). Our research is supported by grants from the Medical Research Council, Action Medical Research and the European Union.

Publications

    Awards

    Marie-Sklodowska Curie Actions, European Training Network ARCH: Age-related changes in Hematopoiesis, 2019-2023

    MRC Research Grant, Identification of novel mechanisms of fetal-hemoglobin induction by common genetic variation in patients with sickle cell disease, 2020-2023 (Co-PI with Dr Stephan Menzel)

    Action Medical Research Project Grant, Investigating the role of transcription factor GATA1 in Diamond-Blackfan Anaemia pathogenesis and diagnosis, 2021-2023

    Marie-Sklodowska Curie Actions Individual Fellowship-European, The molecular basis of ineffective erythropoiesis in Sickle Cell Disease, 2022-2024 (MSCA Fellow: Dr Sara El Hoss).

    Publications

      Awards

      Marie-Sklodowska Curie Actions, European Training Network ARCH: Age-related changes in Hematopoiesis, 2019-2023

      MRC Research Grant, Identification of novel mechanisms of fetal-hemoglobin induction by common genetic variation in patients with sickle cell disease, 2020-2023 (Co-PI with Dr Stephan Menzel)

      Action Medical Research Project Grant, Investigating the role of transcription factor GATA1 in Diamond-Blackfan Anaemia pathogenesis and diagnosis, 2021-2023

      Marie-Sklodowska Curie Actions Individual Fellowship-European, The molecular basis of ineffective erythropoiesis in Sickle Cell Disease, 2022-2024 (MSCA Fellow: Dr Sara El Hoss).

      Lab Members

      Our Partners

      Action Medical Research's logo reading: supported by medical research for children, charity reg. nos 208701 and SC039284

      Action Medical Research

      Marie Skłodowska-Curie Actions logo new

      Marie Skłodowska-Curie Actions

      MRC new logo

      Medical Research Council